Merck · 1 day ago
Associate Director U.S. Marketing, Future Strategy & Life Cycle Management (LCM), Respiratory BU
Merck is dedicated to delivering breakthrough innovations that improve the lives of respiratory patients worldwide. The Associate Director U.S. Marketing, Future Strategy & LCM will play a strategic role in supporting the commercial success of newly acquired COPD assets, coordinating cross-functional activities and advancing lifecycle planning efforts.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Support the Director in implementing and continuously refining an integrated set of choices within the current business model for the respiratory portfolio, including key components such as HUB operations, data integrations, and specialty pharmacy network considerations
Conduct analytical assessments and scenario modeling to inform prioritization and alignment of investments across customers, areas, and commercial levers within the business model
Monitor and synthesize competitive intelligence, access dynamics, and relevant policy developments to identify implications for both current and future respiratory assets
Partner with marketing team to ensure an integrated set of choices across customer type (e.g., consumer, payer, hcp) that considers all interdependencies across data systems, HUB, and specialty pharmacy network etc
Lead operational components of lifecycle planning activities, including developing frameworks, market research, forecasts, timelines, analyses, and cross-functional alignment tools to support U.S. input into global clinical studies, combinations, and development planning. Ensure insights, risks, and dependencies are captured and communicated to the Director to support ongoing strategic refinement
Generate U.S. input into future clinical studies & combinations and provide US POV on stage-gate and development plan decisions
Conduct structured assessments of future commercial opportunities to support U.S. business development evaluations in partnership with payer marketing and global commercial teams. Help define the U.S. future potential for new products in the respiratory space
Coordinate with Product Marketing Owners and Customer Agile Teams to ensure alignment and integration of lifecycle and future strategy elements into customer-level strategy and execution plans
Maintain clear governance, documentation, and tracking mechanisms that enable visibility into progress, risks, and dependencies across lifecycle and strategy initiatives
As a member of the US Pharma Respiratory marketing team, partner with fellow colleagues to invest in each other’s development, build a culture of inclusivity, psychological safety, transparency and stretch our collective team’s thinking by challenging the status quo for the purpose of creating stronger outcomes
Qualification
Required
Minimum of 5 years of progressive experience across marketing, sales, market access (or related experiences) in pharmaceutical or biotechnology industry preferably
Pharmaceutical experience required – Respiratory experience preferred
Strong analytical, strategic, and operational planning skills, with the ability to translate complex insights into clear recommendations
Strategic and tactical planning skills
Elevated level of collaborative skills and ability to work across various parts of the organization
High Legal/Compliance IQ
Bachelor's degree or equivalent (BA/BS)
Preferred
Prior experience in design and execution of patient support programs
Prior experience in forecasting new indications, line extensions and/or TAs
Strong communication skills with ability to communicate/engage with senior leaders
Benefits
Medical
Dental
Vision healthcare and other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
Latest News From Euronews | Euronews RSS
2026-01-22
Company data provided by crunchbase